Abstract:Background: With the rapid aging of the global population, the prevalence of mild cognitive impairment (MCI) and dementia is anticipated to surge worldwide. MCI serves as an intermediary stage between normal aging and dementia, necessitating more sensitive and effective screening tools for early identification and intervention. The BrainFx SCREEN is a novel digital tool designed to assess cognitive impairment. This study evaluated its efficacy as a screening tool for MCI in primary care settings, particularly in the context of an aging population and the growing integration of digital health solutions. Objective: The primary objective was to assess the validity, reliability, and applicability of the BrainFx SCREEN (hereafter, the SCREEN) for MCI screening in a primary care context. We conducted an exploratory study comparing the SCREEN with an established screening tool, the Quick Mild Cognitive Impairment (Qmci) screen. Methods: A concurrent mixed methods, prospective study using a quasi-experimental design was conducted with 147 participants from 5 primary care Family Health Teams (FHTs; characterized by multidisciplinary practice and capitated funding) across southwestern Ontario, Canada. Participants included health care practitioners, patients, and FHT administrative executives. Individuals aged ≥55 years with no history of MCI or diagnosis of dementia rostered in a participating FHT were eligible to participate. Participants were screened using both the SCREEN and Qmci. The study also incorporated the Geriatric Anxiety Scale–10 to assess general anxiety levels at each cognitive screening. The SCREEN's scoring was compared against that of the Qmci and the clinical judgment of health care professionals. Statistical analyses included sensitivity, specificity, internal consistency, and test-retest reliability assessments. Results: The study found that the SCREEN's longer administration time and complex scoring algorithm, which is proprietary and unavailable for independent analysis, presented challenges. Its internal consistency, indicated by a Cronbach α of 0.63, was below the acceptable threshold. The test-retest reliability also showed limitations, with moderate intraclass correlation coefficient (0.54) and inadequate κ (0.15) values. Sensitivity and specificity were consistent (63.25% and 74.07%, respectively) between cross-tabulation and discrepant analysis. In addition, the study faced limitations due to its demographic skew (96/147, 65.3% female, well-educated participants), the absence of a comprehensive gold standard for MCI diagnosis, and financial constraints limiting the inclusion of confirmatory neuropsychological testing. Conclusions: The SCREEN, in its current form, does not meet the necessary criteria for an optimal MCI screening tool in primary care settings, primarily due to its longer administration time and lower reliability. As the number of digital health technologies increases and evolves, further testing and refinement of tools such as the SCREEN are essential to ensure their efficacy and reliability in real-world clinical settings. This study advocates for continued research in this rapidly advancing field to better serve the aging population. Trial Registration:

Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care

Development and application progress of cognitive assessment scales

Use of the Dementia Assessment Sheet for Community‐based Integrated Care System 21 Items among Chinese Community‐dwelling Older Adults

Screening for Dementia in Older Adults: Comparison of Mini-Mental State Examination, Mini-Cog, Clock Drawing Test and AD8

Validity, Feasibility and Effectiveness of a Voice‐recognition Based Digital Cognitive Screener for Dementia and Mild Cognitive Impairment in Community‐dwelling Older Chinese Adults: A Large‐scale Implementation Study

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

Validity, feasibility, and effectiveness of a voice‐recognition based digital cognitive screener for dementia and mild cognitive impairment in community‐dwelling older Chinese adults: A large‐scale implementation study

The Discriminant Validity of Single-Question Assessments of Subjective Cognitive Complaints in an Asian Older Adult Population.

A Mobile Interactive Cognitive Self-Assessment Scale for Screening Alzheimer’s Disease

Unearthing Subtle Cognitive Variations: A Digital Screening Tool for Detecting and Monitoring Mild Cognitive Impairment

Cost-benefit and Discriminant Validity of a Stepwise Dementia Case-Finding Approach in an Asian Older Adult Community

Discriminant Validity and Time‐effectiveness of A Stepwise Dementia Case‐finding Approach in an Asian Elderly Community

Determining Appropriate Screening Tools and Cutoffs for Cognitive Impairment in the Chinese Elderly

Development and validation of cognitive ageing risk score (CARS) for early detection of subtle cognitive deficits in older people

EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE

Automated detection of cognitive impairment in clinical practice

Psychometric Evaluation of a Tablet-Based Tool to Detect Mild Cognitive Impairment in Older Adults: Mixed Methods Study

An effective screening model for subjective cognitive decline in community-dwelling older adults based on gait analysis and eye tracking

Screening Scales for Senile Dementia

Application Study of Quick Cognitive Screening Test in Identifying Mild Cognitive Impairment

Cognitive Abilities Screening Instrument-Chinese Revised Version in Participants with Mild Cognitive Impairment and Alzheimer's Disease